Ethics approval and consent to participate
This study was approved by the University’s Institutional Review Board (IRB #4-2019-1336) and written informed consent was obtained from all individuals participating in the trial. The trial was registered prior to patient enrolment at clinicaltrials.gov (NCT04291339, Principal investigator: Hyun Joo Kim, Date of registration: March 2, 2020).